These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15723622)

  • 21. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.
    Goldenberg DM; Sharkey RM; Paganelli G; Barbet J; Chatal JF
    J Clin Oncol; 2006 Feb; 24(5):823-34. PubMed ID: 16380412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer radioimmunotherapy.
    Sharkey RM; Goldenberg DM
    Immunotherapy; 2011 Mar; 3(3):349-70. PubMed ID: 21395378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pretargeting system for tumor PET imaging and radioimmunotherapy.
    Kraeber-Bodéré F; Rousseau C; Bodet-Milin C; Frampas E; Faivre-Chauvet A; Rauscher A; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J
    Front Pharmacol; 2015; 6():54. PubMed ID: 25873896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA; Meares CF; Osen M
    J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu.
    Mohsin H; Jia F; Bryan JN; Sivaguru G; Cutler CS; Ketring AR; Miller WH; Simón J; Frank RK; Theodore LJ; Axworthy DB; Jurisson SS; Lewis MR
    Bioconjug Chem; 2011 Dec; 22(12):2444-52. PubMed ID: 22053899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers.
    Green DJ; Frayo SL; Lin Y; Hamlin DK; Fisher DR; Frost SH; Kenoyer AL; Hylarides MD; Gopal AK; Gooley TA; Orozco JJ; Till BG; O'Steen S; Orcutt KD; Wilbur DS; Wittrup KD; Press OW
    Cancer Res; 2016 Nov; 76(22):6669-6679. PubMed ID: 27590740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
    Hamblett KJ; Press OW; Meyer DL; Hamlin DK; Axworthy D; Wilbur DS; Stayton PS
    Bioconjug Chem; 2005; 16(1):131-8. PubMed ID: 15656584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
    Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten.
    Gautherot E; Bouhou J; Le Doussal JM; Manetti C; Martin M; Rouvier E; Barbet J
    Cancer; 1997 Dec; 80(12 Suppl):2618-23. PubMed ID: 9406716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
    Kraeber-Bodéré F; Faivre-Chauvet A; Ferrer L; Vuillez JP; Brard PY; Rousseau C; Resche I; Devillers A; Laffont S; Bardiès M; Chang K; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3973S-81S. PubMed ID: 14506196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretargeting with the affinity enhancement system for radioimmunotherapy.
    Barbet J; Kraeber-Bodéré F; Vuillez JP; Gautherot E; Rouvier E; Chatal JF
    Cancer Biother Radiopharm; 1999 Jun; 14(3):153-66. PubMed ID: 10850300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.
    Moosmayer D; Berndorff D; Chang CH; Sharkey RM; Rother A; Borkowski S; Rossi EA; McBride WJ; Cardillo TM; Goldenberg DM; Dinkelborg LM
    Clin Cancer Res; 2006 Sep; 12(18):5587-95. PubMed ID: 17000696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivalent interactions between streptavidin-based pretargeting fusion proteins and cell receptors impede efficient internalization of biotinylated nanoparticles.
    Parker CL; Yang Q; Yang B; McCallen JD; Park SI; Lai SK
    Acta Biomater; 2017 Nov; 63():181-189. PubMed ID: 28870833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bivalent hapten-bearing peptides designed for iodine-131 pretargeted radioimmunotherapy.
    Janevik-Ivanovska E; Gautherot E; Hillairet de Boisferon M; Cohen M; Milhaud G; Tartar A; Rostene W; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 1997; 8(4):526-33. PubMed ID: 9258451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
    Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM
    J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry.
    van de Watering FC; Rijpkema M; Robillard M; Oyen WJ; Boerman OC
    Front Med (Lausanne); 2014; 1():44. PubMed ID: 25593917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy.
    Gruaz-Guyon A; Janevik-Ivanovska E; Raguin O; De Labriolle-Vaylet C; Barbet J
    Q J Nucl Med; 2001 Jun; 45(2):201-6. PubMed ID: 11476171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.
    Vuillez JP; Kraeber-Bodéré F; Moro D; Bardiès M; Douillard JY; Gautherot E; Rouvier E; Barbet J; Garban F; Moreau P; Chatal JF
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3259s-3267s. PubMed ID: 10541373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.